End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.084 AUD | -1.18% | +3.70% | +42.37% |
Jun. 03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
May. 29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Quotes 5-day view
End-of-day quote Australian S.E.2024-06-03 | 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
---|---|---|---|---|---|
Last | 0.089 $ | 0.089 $ | 0.087 $ | 0.085 $ | 0.084 $ |
Volume | 2 428 157 | 2 964 874 | 975 127 | 928 355 | 761 268 |
Change | +9.88% | 0.00% | -2.25% | -2.30% | -1.18% |
Opening | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 |
High | 0.09 | 0.10 | 0.09 | 0.09 | 0.09 |
Low | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 |
Performance
1 day | -1.18% | ||
1 week | +3.70% | ||
Current month | +3.70% | ||
1 month | +10.53% | ||
3 months | -1.18% | ||
6 months | +50.00% | ||
Current year | +42.37% | ||
1 year | +10.53% | ||
3 years | -60.93% | ||
5 years | +78.72% | ||
10 years | -40.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.18% | +3.70% | +42.37% | +10.53% | 49.86M | ||
-0.44% | +2.20% | +18.10% | +41.09% | 125B | ||
-0.65% | +0.56% | +13.29% | +31.97% | 108B | ||
-2.43% | -5.05% | -7.45% | -11.03% | 24.21B | ||
-1.13% | +0.92% | +2.07% | -5.24% | 22.78B | ||
-0.39% | -1.59% | -10.79% | -28.80% | 17.96B | ||
-0.45% | +0.66% | -41.74% | -37.14% | 16.43B | ||
+0.15% | +6.83% | -13.38% | -26.72% | 16.37B | ||
-1.37% | -4.96% | +0.93% | +42.24% | 13.58B | ||
-0.10% | -0.93% | +27.63% | -5.38% | 11.66B | ||
+3.06% | +4.73% | +89.04% | +200.44% | 9.17B | ||
+0.50% | +14.61% | -23.75% | -32.82% | 8.31B | ||
-1.98% | -0.56% | +6.83% | +44.29% | 7.87B | ||
+0.80% | -0.67% | +14.26% | +38.28% | 7.72B | ||
-0.04% | -1.48% | -5.59% | +22.34% | 7.29B | ||
+0.29% | +13.52% | +38.37% | +51.84% | 6.47B | ||
Average | -0.33% | +2.48% | +9.39% | +20.99% | ||
Weighted average by Cap. | -0.53% | +3.41% | +9.41% | +24.45% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +42.37% | ||
2023 | -39.18% | ||
2022 | -50.26% | ||
2021 | +50.00% | ||
2020 | +44.44% | ||
2019 | +246.15% | ||
2018 | +8.33% | ||
2017 | -33.33% | ||
2016 | -49.30% | ||
2015 | -21.11% | ||
2014 | -40.00% | ||
2013 | +36.36% | ||
2012 | -52.17% | ||
2011 | +228.57% | ||
2010 | -87.27% | ||
2009 | +57.14% | ||
2008 | -16.67% | ||
2007 | +5.01% | ||
2006 | +11.10% | ||
2005 | -71.20% | ||
2004 | 0.00% | ||
2003 | +76.05% | ||
2002 | -74.18% | ||
2001 | +14.58% |
- Stock Market
- Equities
- PER Stock
- Quotes Percheron Therapeutics Limited